Back to results
US 2026/0098039 A1Published application
Solid forms of compound i or salts thereof
AssigneeJacobio Pharmaceuticals Co., Ltd.
InventorsHaijun LI, Mingming CHEN, Di KANG, Chaojie DANG, Amin LI, Yanping WANG, Wei LONG
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel forms of Compound I, preparation thereof, pharmaceutical composition containing the same and use thereof, wherein, the compound is (S)-5-((1-(3-(5-methyl-3-(trifluoromethyl)-8,9-dihydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazin-7(6H)-yl)-3-oxopropoxy)propan-2-yl)oxy)-4-(trifluoromethyl)pyridazin-3(2H)-one.
Claims23
A form of Compound I, which is selected from the group consisting of:
- A crystalline of Compound I;
- A salt of Compound I with an acid;
- and
- A crystalline of the salt of Compound I with an acid;
- Wherein, the Compound I is
- The acid is selected from the group consisting of hydrochloric acid, sulfuric acid, hydrobromic acid, methanesulfonic acid, tosic acid, oxalic acid, maleic acid, phosphoric acid, L-tartric acid, fumaric acid, citric acid, lactobionic acid, mandelic acid, L-malic acid, hippuric acid, L-lactic acid, succinic acid, benzoic acid, adipic acid, and acetic acid.
3 more elements
14-21. (canceled)
23-25. (canceled)
29-31. (canceled)
Dependencies are inferred from the claim text.